Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 3Lymphoma 2Leukemia, Myeloid, Acute 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Lymphoma, Follicular 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumor and Lymphoma Malignancies 1Advanced Solid Neoplasms 1

Interventions

TAK-659 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Tumor and Lymphoma Malignancies × TAK-659 × Clear all
NCT02000934 2023-02-08

A Study of TAK-659 in Adult Participants With Advanced Solid Tumor and Lymphoma Malignancies

Calithera Biosciences, Inc

Phase 1 Completed
143 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumor and Lymphoma Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡